AUTL
Autolus Therapeutics Ltd
NASDAQ: AUTL · HEALTHCARE · BIOTECHNOLOGY
$1.41
+0.00% today
Updated 2026-04-30
Market cap
$375.26M
P/E ratio
—
P/S ratio
347.95x
EPS (TTM)
$-1.08
Dividend yield
—
52W range
$1 – $3
Volume
1.7M
Autolus Therapeutics Ltd (AUTL) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2015 | 2016 | 2017 | 2018 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $94112.00 | $1.21M | $1.69M | $1.05M | $1.05M | $2.91M | $1.72M | $1.51M | $6.19M | $1.70M | $10.12M | $75.56M |
| Revenue growth (YoY) | — | +1187.8% | +39.7% | -38.3% | +0.0% | +178.2% | -41.0% | -12.1% | +311.0% | -72.6% | +496.0% | +646.7% |
| Cost of revenue | $0.00 | $478000.00 | $1.01M | $48.30M | $48.30M | $105.42M | $134.89M | $128.65M | $137.22M | $6.57M | $141.02M | $96.37M |
| Gross profit | $94112.00 | $734000.00 | $684000.00 | $-47.25M | $-47.25M | $-102.51M | $-133.17M | $1.51M | $6.19M | $1.70M | $-130.90M | $-21.03M |
| Gross margin | 100.0% | 60.6% | 40.4% | -4520.4% | -4520.4% | -3525.1% | -7765.2% | 100.0% | 100.0% | 100.0% | -1293.5% | -27.8% |
| R&D | $2.17M | $10.44M | $16.01M | $24.64M | $24.64M | $105.62M | $134.99M | $110.84M | $117.35M | $130.48M | $158.14M | $117.69M |
| SG&A | $6.04M | $5.15M | $9.10M | $16.85M | $16.85M | $39.45M | $34.97M | $31.86M | $31.90M | $46.74M | $101.09M | $131.87M |
| Operating income | $-8.11M | $-14.38M | $-23.42M | $-57.53M | $-57.53M | $-247.58M | $-303.13M | $-140.37M | $-142.89M | $-179.70M | $-241.43M | $-281.44M |
| Operating margin | -8613.8% | -1186.1% | -1383.2% | -5503.7% | -5503.7% | -8513.8% | -17675.4% | -9314.8% | -2307.0% | -10583.1% | -2385.6% | -372.4% |
| EBITDA | $-4.47M | $-13.90M | $-22.41M | $-35.21M | $-50.32M | $-137.40M | $-162.58M | $-132.47M | $-132.24M | $-156.77M | $-233.07M | $-271.60M |
| EBITDA margin | -4749.8% | -1146.7% | -1323.6% | -3368.2% | -4813.9% | -4724.8% | -9479.8% | -8790.6% | -2135.0% | -9232.6% | -2303.1% | -359.4% |
| EBIT | $-8.11M | $-14.38M | $-23.42M | $-36.31M | $-52.03M | $-141.96M | $-168.15M | $-140.93M | $-139.66M | $-163.34M | $-240.79M | $-281.44M |
| Interest expense | $0.00 | $49000.00 | $38000.00 | $12667.00 | $12667.00 | $1.15M | $1.89M | $1.10M | $8.90M | $45.07M | $9.29M | $36.76M |
| Income tax | — | — | — | — | — | — | — | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $-7.46M | $-12.55M | $-19.73M | $-31.11M | $-31.11M | $-123.85M | $-142.09M | $-142.10M | $-148.84M | $-208.38M | $-220.66M | $-287.53M |
| Net income growth (YoY) | — | -68.1% | -57.2% | -57.7% | +0.0% | -298.0% | -14.7% | -0.0% | -4.7% | -40.0% | -5.9% | -30.3% |
| Profit margin | -7931.1% | -1035.5% | -1165.2% | -2976.5% | -2976.5% | -4258.9% | -8285.4% | -9429.1% | -2403.0% | -12272.3% | -2180.5% | -380.5% |